Trial Profile
Multicenter open-label RCT to compare colistin alone vs. colistin plus meropenem Trial [randomizzato controllato multicentrico per la valutazione dell'efficacia di colistina rispetto a colistina e meropenem nel trattamento delle infezioni severe da batteri gram negativi multi resistenti]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Colistin (Primary) ; Meropenem (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- Acronyms AIDA
- 16 Apr 2019 Results testing association between in vitro synergy and mortality in patients in the AIDA trial who were treated with colistin-meropenem presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases
- 18 Sep 2013 New trial record